Tenaya Therapeutics Inc
General ticker "TNYA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $249.7M
Tenaya Therapeutics Inc does not follow the US Stock Market performance with the rate: -18.9%.
Estimated limits based on current volatility of 28.5%: low 0.97$, high 1.74$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.59$, 4.28$]
- 2024-12-30 to 2025-12-30 estimated range: [1.81$, 4.65$]
Financial Metrics affecting the TNYA estimates:
- Negative: Non-GAAP EPS, $ of -1.67 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -38.84 <= 2.35
- Negative: negative Net income
Short-term TNYA quotes
Long-term TNYA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $72.81MM | $125.62MM | $131.19MM |
| Operating Income | $-72.81MM | $-125.62MM | $-131.19MM |
| Non-Operating Income | $0.09MM | $1.96MM | $7.11MM |
| R&D Expense | $54.39MM | $94.54MM | $98.04MM |
| Income(Loss) | $-72.72MM | $-123.67MM | $-124.08MM |
| Profit(Loss) | $-72.72MM | $-123.67MM | $-124.08MM |
| Stockholders Equity | $278.53MM | $243.38MM | $139.42MM |
| Inventory | $0.00MM | $19.95MM | $0.00MM |
| Assets | $314.19MM | $278.94MM | $170.51MM |
| Operating Cash Flow | $-60.81MM | $-104.42MM | $-102.07MM |
| Capital expenditure | $25.12MM | $20.63MM | $1.24MM |
| Investing Cash Flow | $-238.56MM | $83.65MM | $48.72MM |
| Financing Cash Flow | $208.97MM | $77.77MM | $4.05MM |
| Earnings Per Share* | $-1.69 | $-2.76 | $-1.68 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.